Reduced Fresnel losses in chalcogenide fibers by using anti-reflective surface structures on fiber end faces von Sanghera, Jasbinder, Florea, Catalin, Busse, Lynda, Shaw, Brandon, Miklos, Fritz, Aggarwal, Ishwar

Volltext

Reduced Fresnel losses in chalcogenide fibers by using anti-reflective surface structures on fiber end faces von Sanghera, Jasbinder, Florea, Catalin, Busse, Lynda, Shaw, Brandon, Miklos, Fritz, Aggarwal, Ishwar

Volltext

10% Yb3+-Lu2O3 ceramic laser with 74% efficiency von SANGHERA, Jas, FRANTZ, J, AGGARWAL, Ishwar, KIM, Woohong, VILLALOBOS, Guillermo, BAKER, Colin, SHAW, Brandon, SADOWSKI, Bryan, HUNT, Michael, MIKLOS, Fritz, LUTZ, Austin

Volltext

Low absorption magnesium aluminate spinel windows for high energy laser applications von Villalobos, Guillermo, Bayya, Shyam, Kim, Woohong, Baker, Colin, Sanghera, Jas, Hunt, Michael, Sadowski, Bryan, Miklos, Fritz, Aggarwal, Ishwar

Volltext

Reduced Fresnel losses in chalcogenide fibers obtained through fiber-end microstructuring von Florea, Catalin, Sanghera, Jasbinder, Busse, Lynda, Shaw, Brandon, Miklos, Fritz, Aggarwal, Ishwar

Volltext

10% Yb^3+-Lu_2O_3 ceramic laser with 74% efficiency von Sanghera, Jas, Frantz, J., Kim, Woohong, Villalobos, Guillermo, Baker, Colin, Shaw, Brandon, Sadowski, Bryan, Hunt, Michael, Miklos, Fritz, Lutz, Austin, Aggarwal, Ishwar

Volltext

Reduced Fresnel Losses in Chalcogenide Fibers by Using Anti-Reflective Surface Structures on Fiber End Faces von Sanghera, Jasbinder, Florea, Catalin, Busse, Lynda, Shaw, Brandon, Miklos, Fritz, Aggarwal, Ishwar

Volltext bestellen

Effects of branched-chain amino acids on changes in body composition during the recovery period following tonsillectomy von Fritz, Réka, Kiricsi, Ágnes, Csanády, Miklós, Fritz, Péter

Volltext

Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition von Reinhart, Sophie, Trachsel, Yasmin, Fritz, Christine, Wagner, Ulrich, Bode-Lesniewska, Beata, John, Hubert, Pless, Miklos

Volltext

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicent... von Dimopoulos, Meletios A, Prof, Moreau, Philippe, Prof, Palumbo, Antonio, Prof, Joshua, Douglas, Prof, Pour, Ludek, Prof, Hájek, Roman, Prof, Facon, Thierry, Prof, Ludwig, Heinz, Prof, Oriol, Albert, Prof, Goldschmidt, Hartmut, Prof, Rosiñol, Laura, Prof, Straub, Jan, Prof, Suvorov, Aleksandr, Prof, Araujo, Carla, Prof, Rimashevskaya, Elena, Prof, Pika, Tomas, Prof, Gaidano, Gianluca, Prof, Weisel, Katja, Prof, Goranova-Marinova, Vesselina, Prof, Schwarer, Anthony, Prof, Minuk, Leonard, Prof, Masszi, Tamás, Prof, Karamanesht, Ievgenii, Prof, Offidani, Massimo, Prof, Hungria, Vania, Prof, Spencer, Andrew, Prof, Orlowski, Robert Z, MD, Gillenwater, Heidi H, MD, Mohamed, Nehal, PhD, Feng, Shibao, PhD, Chng, Wee-Joo, Prof

Volltext

Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial von Kalakonda, Nagesh, Maerevoet, Marie, Cavallo, Federica, Follows, George, Goy, Andre, Vermaat, Joost S P, Casasnovas, Olivier, Hamad, Nada, Zijlstra, Josée M, Bakhshi, Sameer, Bouabdallah, Reda, Choquet, Sylvain, Gurion, Ronit, Hill, Brian, Jaeger, Ulrich, Sancho, Juan Manuel, Schuster, Michael, Thieblemont, Catherine, De la Cruz, Fátima, Egyed, Miklos, Mishra, Sourav, Offner, Fritz, Vassilakopoulos, Theodoros P, Warzocha, Krzysztof, McCarthy, Daniel, Ma, Xiwen, Corona, Kelly, Saint-Martin, Jean-Richard, Chang, Hua, Landesman, Yosef, Joshi, Anita, Wang, Hongwei, Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Van Den Neste, Eric, Canales, Miguel A

Volltext

Inflammatory Myofibroblastic Tumor of the Bladder With FN1-ALK Gene Fusion: Different Response to ALK Inhibition von Reinhart, Sophie, Trachsel, Yasmin, Fritz, Christine, Wagner, Ulrich, Bode-Lesniewska, Beata, John, Hubert, Pless, Miklos

Volltext

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial von Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

Volltext

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial von Barrington, Sally F, Belada, David, Meignan, Michel, Ptáčník, Václav, Fingerle-Rowson, Günter R, Hiddemann, Wolfgang, Marcus, Robert E, Grigg, Andrew, Quach, Hang, Marlton, Paula, Offner, Fritz, Van eygen, Koen, Roitman, Daryl, Trneny, Marek, Le Du, Katell, Solal-Celigny, Philippe, Cartron, Guillaume, Foussard, Charles, Schmidt, Peter, Sökler, Martin, Schimmelpfennig, Christoph, Tonndorf, Solveig, Hänel, Mathias, Hess, Georg, Schalk, Enrico, Pfreundschuh, Michael, Herold, Michael, Forstpointner, Roswitha, Vehling-Kaiser, Ursula, Majolino, Ignazio, Balzarotti, Monica, Soler Campos, Alfonso, Marquez Navarro, Jose Antonio, Grande Garcia, Carlos, Nilsson-Ehle, Herman, Radford, John, Kruger, Anton, Culligan, Dominic, Dyer, Martin, Pettengell, Ruth, Al-Ismail, Saad, Al-Refaie, Faris, Blesing, Norbert, Macnamara, Christopher, O'callaghan, Ann, Haynes, Andrew, Bowles, Kristian, Gallop-Evans, Eve, Bailey, James, De Oliveira, Moacyr, Tezcan, Haluk, Kim, Kevin, Hatake, Kiyohiko, Ogura, Michinori, Uchida, Toshiki, Kinoshita, Tomohiro, Kirsch, Andreas, Koenigsmann, Michael, Dürig, Jan, Kneba, Michael, Bergmann, Lothar, Marks, Reinhard, Wulf, Gerald, Schmits, Rudolf, Lengfelder, Eva, Scott, Fiona, Taniwaki, Masafumi, Yoshida, Isao, Uike, Naokuni, Kamitsuji, Yuri, Iida, Shinsuke, Ohmine, Ken, Nosaka, Kisato, Ide, Kazuhiko, Ishikawa, Takayuki, Li, Wei, Yu, Li, Shi, Yuan Kai, Hong, Xiaonan, Feng, Jifeng, Zhan, Rong, Lin, Tongyu, Costello, Regis, Tournilhac, Olivier, Kirchen, Heinz, Hebart, Holger, Gurion, Ronit, Shpilberg, Ofer, Leoni, Pietro, Samoylova, Olga, Usui, Noriko, Izutsu, Koji, Ichinohe, Tatsuo, Kubo, Kohmei, Ishida, Fumihiro, Dakhil, Shaker, Maruyama, Dai, Kobayashi, Tsutomu, Wada, Katsuya, Minami, Yosuke

Volltext

Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma von Robak, Tadeusz, Huang, Huiqiang, Jin, Jie, Zhu, Jun, Liu, Ting, Samoilova, Olga, Pylypenko, Halyna, Verhoef, Gregor, Siritanaratkul, Noppadol, Osmanov, Evgenii, Alexeeva, Julia, Pereira, Juliana, Drach, Johannes, Mayer, Jiri, Hong, Xiaonan, Okamoto, Rumiko, Pei, Lixia, Rooney, Brendan, van de Velde, Helgi, Cavalli, Franco

Volltext

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicen... von BETTICHER, Daniel C, SCHMITZ, Shu-Fang Hsu, SPILIOPOULOS, Anastase, STAHEL, Rolf, WEDER, Walter, STUPP, Roger, EGLI, Fritz, FURRER, Markus, HONEGGER, Hanspeter, WERNLI, Martin, CERNY, Thomas, RIS, Hans-Beat, TÖTSCH, Martin, HANSEN, Eva, JOSS, Christine, VON BRIEL, Christian, SCHMID, Ralph A, PLESS, Miklos, HABICHT, James, ROTH, Arnaud D

Volltext

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial von Coiffier, Bertrand, Prof, Osmanov, Evgenii A, Prof, Hong, Xiaonan, Prof, Scheliga, Adriana, MD, Mayer, Jiri, Prof, Offner, Fritz, Prof, Rule, Simon, MD, Teixeira, Adriana, MD, Walewski, Jan, Prof, de Vos, Sven, MD, Crump, Michael, Prof, Shpilberg, Ofer, Prof, Esseltine, Dixie-Lee, MD, Zhu, Eugene, PhD, Enny, Christopher, BS, Theocharous, Panteli, PhD, van de Velde, Helgi, MD, Elsayed, Yusri A, MD, Zinzani, Pier Luigi, Prof

Volltext

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study von Maerevoet, Marie, Zijlstra, Josee M, Follows, George, Casasnovas, Rene-Olivier, Vermaat, J. S. P, Kalakonda, Nagesh, Goy, Andre, Choquet, Sylvain, Van Den Neste, Eric, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, De la Cruz, Fatima, Kuruvilla, John, Hamad, Nada, Jaeger, Ulrich, Caimi, Paolo, Gurion, Ronit, Warzocha, Krzysztof, Bakhshi, Sameer, Sancho, Juan-Manuel, Schuster, Michael, Egyed, Miklos, Offner, Fritz, Vassilakopoulos, Theodoros P, Samal, Priyanka, Ku, Matthew, Ma, Xiwen, Corona, Kelly, Chamoun, Kamal, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G, Canales, Miguel

Volltext

Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sa... von Cavallo, Federica, Follows, George A, Goy, Andre, Vermaat, Joost, Casasnovas, Rene-Olivier, Lavee, Orly, Maerevoet, Marie, Zijlstra, Josée M, Bakhshi, Sameer, Bouabdallah, Reda, Choquet, Sylvain, Gurion, Ronit, Hill, Brian T., Jaeger, Ulrich, Sancho, Juan-Manuel, Schuster, Michael W., Thieblemont, Catherine, De la Cruz, Fatima, Egyed, Miklos, Mishra, Sourav, Offner, Fritz, Vassilakopoulos, Theodoros P., Warzocha, Krzysztof, McCarthy, Daniel, Ma, Xiwen, Corona, Kelly, Saint-Martin, Jean-Richard, Joshi, Anita, Shah, Jatin, Van Den Neste, Eric, Canales, Miguel A, Kalakonda, Nagesh

Volltext

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial von Ocvirk, Janja, Brodowicz, Thomas, Wrba, Fritz, Ciuleanu, Tudor E, Kurteva, Galina, Beslija, Semir, Koza, Ivan, Pápai, Zsuzsanna, Messinger, Diethelm, Yilmaz, Ugur, Faluhelyi, Zsolt, Yalcin, Suayib, Papamichael, Demetris, Wenczl, Miklós, Mrsic-Krmpotic, Zrinka, Shacham-Shmueli, Einat, Vrbanec, Damir, Esser, Regina, Scheithauer, Werner, Zielinski, Christoph C

Volltext